World's Best Scientists 2026 revealed!
Paul J. Kurtin

Paul J. Kurtin

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 89 12814 12059 6548 6055 287 25169

Paul J. Kurtin publications per year

The chart shows the history of publications by Paul J. Kurtin between 1983 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Paul J. Kurtin published across 41 years, from 1983 to 2023, averaging 7 papers a year. Output peaked at 16 publications in 2005. 5 of the 289 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1983 to 2023. Vertical axis: number of publications, 0 to 16. Peak 16 publications in 2005. 1983: 1 publication 1984: 0 publications 1985: 2 publications 1986: 1 publication 1987: 0 publications 1988: 0 publications 1989: 3 publications 1990: 3 publications 1991: 4 publications 1992: 9 publications 1993: 4 publications 1994: 7 publications 1995: 5 publications 1996: 9 publications 1997: 6 publications 1998: 6 publications 1999: 7 publications 2000: 11 publications 2001: 12 publications 2002: 11 publications 2003: 5 publications 2004: 9 publications 2005: 16 publications 2006: 12 publications 2007: 10 publications 2008: 11 publications 2009: 11 publications 2010: 7 publications 2011: 8 publications 2012: 5 publications 2013: 10 publications 2014: 9 publications 2015: 10 publications 2016: 13 publications 2017: 15 publications 2018: 12 publications 2019: 5 publications 2020: 7 publications 2021: 8 publications 2022: 4 publications 2023: 1 publication
1983 2023

289 publications in total across all disciplines

View publications per year as a table
Paul J. Kurtin: publications per year, 1983 to 2023
Year Publications
1983 1
1984 0
1985 2
1986 1
1987 0
1988 0
1989 3
1990 3
1991 4
1992 9
1993 4
1994 7
1995 5
1996 9
1997 6
1998 6
1999 7
2000 11
2001 12
2002 11
2003 5
2004 9
2005 16
2006 12
2007 10
2008 11
2009 11
2010 7
2011 8
2012 5
2013 10
2014 9
2015 10
2016 13
2017 15
2018 12
2019 5
2020 7
2021 8
2022 4
2023 1
Total 289
Download as CSV

Paul J. Kurtin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul J. Kurtin sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 281–300 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 287 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768 287
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Paul J. Kurtin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul J. Kurtin sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 88–89 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970 89
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Paul J. Kurtin is affiliated with the Mayo Clinic in the United States and has a research focus primarily in medicine and biochemistry, genetics, and molecular biology. Their body of work spans key subfields such as molecular biology, pathology and forensic medicine, genetics, oncology, and nephrology.

The scientist's research extensively covers clinical and molecular aspects of amyloidosis and lymphoma diagnosis and treatment. Their main topics of study include:

  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Lymphoma Diagnosis and Treatment
  • Parathyroid Disorders and Treatments
  • Peptidase Inhibition and Analysis
  • Cancer-related Gene Regulation
  • Neuroendocrine Tumor Research Advances
  • Dermatological and Skeletal Disorders

Recent notable publications include:

  • "Systemic amyloidosis from A (AA) to T (ATTR): a review" (2020, Journal of Internal Medicine)
  • "Amyloid Typing by Mass Spectrometry in Clinical Practice: a Comprehensive Review of 16,175 Samples" (2020, Mayo Clinic Proceedings)
  • "Association between spinal stenosis and wild-type ATTR amyloidosis" (2021, Amyloid)
  • "Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma" (2020, The American Journal of Surgical Pathology)
  • "High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?" (2020, Blood Cancer Journal)

Frequent co-authors in their scholarly work are:

  • Ellen D. McPhail
  • Surendra Dasari
  • Jason D. Theis
  • Karen L. Rech
  • Angela Dispenzieri

The venues where Kurtin has most regularly published include:

  • Amyloid
  • Human Pathology
  • The American Journal of Surgical Pathology
  • Blood Cancer Journal
  • Journal of Internal Medicine

This profile reflects a focused expertise in the clinical and molecular pathology related to amyloidosis and lymphoma, supported by a consistent pattern of contributions in relevant peer-reviewed journals and collaborations with other researchers in adjacent fields.

Best Publications

  • Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

    Robert A. Kyle;Ellen D. Remstein;Terry M. Therneau;Angela Dispenzieri

  • The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

    Kerry J. Savage;Stefano Monti;Jeffery L. Kutok;Giorgio Cattoretti

  • Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response

    Stefano Monti;Kerry J. Savage;Jeffery L. Kutok;Friedrich Feuerhake

  • Lymphoid Neogenesis in Rheumatoid Synovitis

    Seisuke Takemura;Andrea Braun;Cynthia Crowson;Paul J. Kurtin

  • Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

    Thomas E. Witzig;Susan M. Geyer;Irene Ghobrial;David J. Inwards

  • Epithelial membrane antigen--a diagnostic discriminant in surgical pathology: immunohistochemical profile in epithelial, mesenchymal, and hematopoietic neoplasms using paraffin sections and monoclonal antibodies.

    Geraldine S. Pinkus;Paul J. Kurtin

  • The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

    Janet E. Olson;Carol A. Janney;Ravi D. Rao;James R. Cerhan

  • Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

    Matthew J. Maurer;Hervé Ghesquières;Hervé Ghesquières;Jean Philippe Jais;Thomas E. Witzig

  • Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.

    Jane N. Winter;Edie A. Weller;Sandra J. Horning;Maryla Krajewska

  • BLyS and APRIL in rheumatoid arthritis

    Thorsten M. Seyler;Yong W. Park;Yong W. Park;Seisuke Takemura;Richard J. Bram

  • NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes

    Friedrich Feuerhake;Jeffery L. Kutok;Stefano Monti;Wen Chen

  • Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas.

    Ellen D. Remstein;C. David James;Paul J. Kurtin

  • Leukocyte common antigen—a diagnostic discriminant between hematopoietic and nonhematopoietic neoplasms in paraffin sections using monoclonal antibodies: Correlation with immunologic studies and ultrastructural localization

    Paul J. Kurtin;Geraldine S. Pinkus

  • Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

    Andrew L. Feldman;Mark Law;Ellen D. Remstein;William R. Macon

  • Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

    William R. Macon;Norman B. Levy;Paul J. Kurtin;Kevin E. Salhany

  • Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT type.

    Paul Kurtin;Jeffrey Myers;Hakiran Adlakha;John Strickler

  • The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.

    Ellen D. Remstein;Ahmet Dogan;Richard R. Einerson;Sarah F. Paternoster

  • Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects.

    Suhail Ahmad;H. Thomas Robertson;Thomas A. Golper;Marsha Wolfson

  • Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: A phase II trial in the north central cancer treatment group

    Thomas E. Witzig;Allen M. Vukov;Thomas M. Habermann;Susan Geyer

  • Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.

    Stephen M. Ansell;David J. Inwards;Kendrith M. Rowland;Patrick J. Flynn

Frequent Co-Authors

Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
Ahmet Dogan
Ahmet Dogan Memorial Sloan Kettering Cancer Center
Surendra Dasari
Surendra Dasari Mayo Clinic
David J. Inwards
David J. Inwards Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
Samih H. Nasr
Samih H. Nasr Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring ways to enter or advance in the medical field, there are a variety of flexible online degree programs and career pathways worth considering. For instance, students interested in administrative roles might look at the medical billing and coding financial aid options available, which help make these programs more accessible and affordable.

Nursing is another popular path, and you may wonder: do you have to take the teas test to get into nursing school? Some accredited nursing schools offer admission without the typical standardized entrance exams, removing barriers for aspiring nurses.

For those aiming for leadership roles, an accelerated healthcare administration degree can quickly prepare you for managerial careers in hospitals, clinics, and beyond.

Registered nurses aiming to become nurse practitioners can consider structured adn to np bridge programs available online, which fast-track career progression without sacrificing work experience.

Each of these options provides a unique route into the healthcare industry, offering flexibility, financial support, and opportunities for advancement.

Best Scientists Citing Paul J. Kurtin

Trending Scientists

Recently Published Articles